Charles Ryan
Listed on 4 Form D filings across 2+ issuers
· Director, Executive Officer
Associated issuers
- Quince Therapeutics, Inc. CIK 1662774 · CA
- Toloka Group, Inc. CIK 2066938 · MA
Filings (4)
-
Quince Therapeutics, Inc.D · Jun 11, 2026 · CA · Biotechnology$186.4MView filing →
-
Quince Therapeutics, Inc.D · Jun 11, 2026 · CA · Biotechnology$7.4MView filing →
-
Quince Therapeutics, Inc.D · Jul 1, 2025 · CA · Biotechnology$21.9MView filing →
-
Toloka Group, Inc.D · May 16, 2025 · MA · Other Technology$90MView filing →